Novel RNA interference-based therapies for sepsis
Authors:
- Dmitriy LukashevDLDmitriy Lukashev
- Lubomir V NechevLNLubomir V Nechev
- Mansoor M AmijiMAMansoor M Amiji
- 8 January 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 14 (4) , 419-435
Abstract
Sepsis is an extremely fast-paced disease, initiated by an infection that can progress to multiple organ dysfunction and death. The complexity associated with sepsis makes the therapies difficult to develop. Moreover, the 'one-fits-all' kind of therapy is far from being realistic. This review provides a conspectus of the current results of sepsis therapies and their benefits, focusing on the development of small interfering RNA (siRNA) therapeutics for targeting immune cells and sepsis pathways. The question, 'When will an effective therapy for sepsis be available for patients?' remains unanswered. New RNA interference-mediated therapies are emerging as novel approaches for the treatment of sepsis by downregulating key inflammatory cytokine expression. Strategies that exploit multimodal gene silencing using siRNA and targeted delivery systems are discussed in this review. Some of these strategies have shown positive results in preclinical model of sepsis.Keywords
This publication has 110 references indexed in Scilit:
- Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patientsExperimental and Therapeutic Medicine, 2013
- Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting CellsMolecular Therapy, 2011
- A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay developmentCytotechnology, 2011
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Targeted Delivery of siRNA to Macrophages for Anti-inflammatory TreatmentMolecular Therapy, 2010
- Nonviral Methods for siRNA DeliveryMolecular Pharmaceutics, 2008
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003